Skip to content

A study for testing whether Guduchi (Tinospora cordifolia) ghana vati along with Tab. Multivitamin is more effective in managing post COVID-19 fatigue than Tab. Multivitamin alone.

Randomized controlled clinical trial of add on effect of Guduchi(Tinospora cordifolia (Wild.)Miers)ghana vati with tab. Multivitamin on post covid- 19 Klama (fatigue)

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/02/050095
Enrollment
48
Registered
2023-02-27
Start date
Unknown
Completion date
Unknown
Last updated
2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: U071- COVID 19 virus identified

Interventions

None listed

Sponsors

Dr. Sneha Patil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients with positive RTPCR test for COVID-19 dating back 20 to 60 days from the date of screening 2.Patients showing symptoms of Fatigue post COVID19.

Exclusion criteria

Exclusion criteria: 1.known cases of immunosuppressive disorders. 2.Known case of or known history of major disorders like Cancer, Renal failure, Cardiac disorders.

Design outcomes

Primary

MeasureTime frame
Guduchi (Tinospora cordyfolia) Ghana vati when used with Tab. Multivitamin releives the symptoms of post COVID-19 klama (fatigue) more effectively than Tab.Multivitamin alone.when tested fatigue with Chalder fatigue scale.Timepoint: follow up on baseline,1st week,2nd week,3rd week

Secondary

MeasureTime frame
Guduchi ghana Vati increases weight of patients when measured with weighing scale, before and after treatment.Timepoint: Follow up on 2nd and 3rd week;Guduchi ghanavati improves Agni of participants when the Abhyavaran shakti of patients compared before and after study.Timepoint: follow up on 2nd and 3rd week

Countries

India

Contacts

Public ContactDr Apoorva Sangoram

Tilak ayurved Mahavidyalaya

apoorvasangoram@gmail.com9822090305

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026